Tesla shares (TSLA)

Executive Summary

Tesla shares advanced 3.21% to $393.45 since the March 25 report, consolidating above the $390 resistance level as investors digest the company's ambitious expansion into chip manufacturing and robotaxi deployment. The rally narrows YTD losses to -12.51% despite mounting concerns over capital intensity, with the upcoming Terafab Project launch and robotaxi market expansion serving as key catalysts offsetting near-term cash flow pressures.

Key Updates

Tesla shares gained 3.21% since the previous March 25 report, holding above the $390 resistance level that was breached in the prior session. The stock has now recovered 6.49% from the March 20 low of $371.53, though remains down -12.51% YTD. The current consolidation occurs amid four significant developments: the Roadster unveiling delay to late April 2025, the imminent Terafab Project launch in 7 days, continued positive analyst sentiment from Bank of America, and strategic pivot toward robotaxis and AI chips at the expense of traditional EV models. The price action reflects investor recalibration between the company's capital-intensive transformation and its autonomous vehicle opportunity valued at over $700 billion by leading analysts.

Current Trend

Tesla exhibits a recovery pattern from oversold levels, advancing 6.49% from the March 20 low of $371.53 to current $393.45. The stock has established $390 as a new support level after breaking resistance, though remains in a downtrend with -12.51% YTD losses. The 6-month decline of -7.07% and 1-month decline of -1.60% indicate persistent selling pressure, while recent 5-day performance of +0.17% suggests stabilization. The recovery from the $371.53 low represents a technical bounce within a broader corrective phase, with the stock trading approximately 13% below Bank of America's $460 price target and 24% below the $488 target cited in earlier coverage.

Investment Thesis

The investment thesis centers on Tesla's transformation from an electric vehicle manufacturer to an autonomous mobility and AI infrastructure company, with robotaxi and Full Self-Driving technology representing the primary value drivers. Bank of America values the autonomous vehicle businesses at $735 billion—comprising $422 billion for robotaxis and $313 billion for FSD software—more than double the $345 billion assigned to the core EV division. The thesis assumes Tesla will achieve $1.58 cost per mile at scale versus $3.41 for traditional ride-sharing, expand robotaxi services from two cities to nine by 2026, and grow FSD customers from 1.1 million to 8.7 million by 2030. The Terafab Project represents strategic vertical integration to address chip supply constraints from TSMC, Samsung, and Micron, targeting AI5 chip volume production in 2027. Additional value drivers include the Optimus humanoid robot (valued over $30 billion) and energy business (valued at $90 billion). The thesis requires successful regulatory approvals in China and Europe, execution on capital expenditure exceeding $20 billion in 2026 (excluding Terafab's estimated $30-300 billion), and market acceptance of the robotaxi model despite anticipated negative free cash flow of $4.1 billion in 2026.

Thesis Status

The investment thesis faces near-term execution risks but maintains structural integrity. New information confirms the strategic pivot toward autonomous vehicles and AI infrastructure, with the Roadster delay and planned discontinuation of Model S and Model X demonstrating capital reallocation toward robotaxis (volume production next month) and Optimus (unveiling by end of March 2025). The Terafab Project launch in 7 days validates concerns about chip supply constraints and represents commitment to vertical integration, though adds significant capital intensity beyond the already elevated $20 billion capex guidance. The thesis is progressing on deployment metrics—robotaxi expansion from two to nine cities by year-end and volume production beginning next month—but faces heightened financial stress with Wall Street projecting negative FCF for the first time since 2018. Analyst support remains robust with Bank of America's buy rating and $460-488 price targets implying 17-24% upside, though the -12.51% YTD performance reflects investor skepticism around execution timing and capital requirements. The 54% valuation weight assigned to robotaxis versus 21% to automotive confirms the thesis evolution is recognized by the market, but low FSD penetration (1.1 million of 8.9 million vehicles) indicates significant adoption challenges remain.

Key Drivers

Four primary catalysts are shaping near-term performance. First, the Terafab Project launching in 7 days represents Tesla's entry into chip manufacturing with projected initial costs of $30 billion and potential $300 billion at full capacity, addressing supply constraints from current partners TSMC, Samsung, and Micron for AI5 chip production targeted for 2027. Second, robotaxi deployment acceleration with volume production beginning next month and expansion from two cities to nine by 2026, with Wall Street projecting 5 million robotaxis by 2035 and Tesla potentially capturing 50% market share. Third, strategic product portfolio realignment with Roadster delayed to late April 2025, Model S and Model X discontinuation later this year, and production capacity redirected toward autonomous vehicles and Optimus humanoid robot unveiling by end of March 2025. Fourth, sustained analyst optimism with Bank of America's buy rating and $460 price target based on camera-only autonomous driving approach offering cost advantages over competitors' multi-sensor systems, though offset by projected negative $4.1 billion FCF in 2026 as the company enters capital-intensive expansion phase.

Technical Analysis

Tesla has established a short-term uptrend from the March 20 low of $371.53, advancing 6.49% to $393.45 and breaking above the $390 resistance level that previously served as support. The stock now trades at $393.45 with $390 as immediate support and $400 as next resistance. Volume patterns show increased buying interest during the recovery, though the -12.51% YTD decline indicates the broader trend remains negative. The 6-month decline of -7.07% and 1-month decline of -1.60% suggest persistent distribution, while the 5-day gain of +0.17% indicates consolidation. The current price sits 13% below Bank of America's $460 target and 24% below the $488 target, creating a technical gap that could serve as upside objective if fundamentals support the autonomous vehicle thesis. Key support levels are $390 (immediate), $380 (prior support broken on March 20), and $371.53 (recent low), while resistance levels are $400 (psychological), $420 (intermediate), and $460-488 (analyst targets). The recovery pattern suggests a technical bounce within a corrective phase rather than trend reversal, requiring sustained movement above $400 to confirm bullish momentum.

Bull Case

• Autonomous vehicle valuation of $735 billion exceeds core EV business: Bank of America assigns $422 billion to robotaxi and $313 billion to FSD software versus $345 billion for automotive, with projected $1.58 cost per mile versus $3.41 for traditional ride-sharing enabling superior unit economics at scale. Source
• Robotaxi market dominance with 50% share potential: Wall Street projects Tesla could capture up to 50% of global robotaxi market with 5 million vehicles by 2035, expanding from two cities currently to nine by 2026 with volume production beginning next month. Source
• Vertical integration through Terafab addresses chip supply constraints: In-house chip manufacturing launching in 7 days eliminates dependence on TSMC, Samsung, and Micron, enabling AI5 chip volume production for 2027 and supporting autonomous vehicle scaling requirements. Source
• Camera-only autonomous approach offers cost advantage: Tesla's vision-based system is more cost-effective than competitors' multi-sensor systems, enabling more profitable scaling and supporting analyst view of clear leadership in autonomous driving technology. Source
• Diversified value drivers beyond automotive: Optimus humanoid robot valued over $30 billion with unveiling by end of March 2025, and energy business valued at $90 billion provide additional growth vectors independent of vehicle sales. Source

Bear Case

• Negative free cash flow of $4.1 billion projected for 2026: Tesla's FCF expected to turn negative for first time since 2018 as capital expenditure exceeds $20 billion excluding Terafab costs, which could reach $30-300 billion, straining financial flexibility during transformation phase. Source
• Low FSD adoption with only 1.1 million of 8.9 million vehicles: Current 12.4% FSD penetration rate requires growth to 8.7 million customers by 2030 to justify valuation, facing significant adoption challenges and requiring regulatory approval in China and Europe. Source
• Strategic product delays and discontinuations weaken near-term revenue: Roadster delayed again to late April 2025 after original 2020 target, Model S and Model X discontinuation later this year reduces product portfolio while robotaxi revenue remains uncertain with only 1,000 vehicles expected by end of 2026. Source
• Massive capital intensity with unproven return profile: Terafab Project requiring $30 billion initially and potentially $300 billion at full capacity adds to $20 billion annual capex, creating execution risk in untested chip manufacturing business while core automotive margins face pressure. Source
• Robotaxi deployment limited to two cities with slow expansion: Current operations in only San Francisco and Austin with seven additional markets planned for first half of year represents minimal scale, while 5 million vehicle target by 2035 requires 9+ years to achieve meaningful market presence. Source